Bayer Voids Singapore Uni's Patent For Fibrosis Treatment
Bayer has persuaded a European appeals panel to revoke a patent for a fibrosis treatment belonging to a Singaporean university and the country's largest public healthcare group....To view the full article, register now.
Already a subscriber? Click here to view full article